Nature Publishing Group to publish Immunology and Cell Biology

Nature Publishing Group (NPG) and the Australasian Society for Immunology (ASI) today announce an agreement for NPG to publish in partnership with the Society its flagship journal, Immunology and Cell Biology, from January 2007.

PRESS RELEASE FROM NATURE PUBLISHING GROUP
27 February 2006

Contact: David Swinbanks
Nature Publishing Group
+81 3 3267 8764

Tokyo-based NPG Publishing Director David Swinbanks said "Immunology and
Cell Biology is a superb addition to the program of partnerships between NPG
Nature Asia-Pacific and key scientific and clinical organizations across the
Asia-Pacific region"

"We are excited to be working with the Australasian Society for Immunology
to further develop a journal with an already well-established reputation for
quality"

"There is tremendous enthusiasm among members of the ASI for this
partnership. We see it is a fantastic opportunity to bring exposure of our
journal to a new level." the President of the ASI, Dr Philip Hodgkin, said
in Melbourne.

Professor Chris Parish, long time Editor of Immunology and Cell Biology
further commented "This represents a wonderful opportunity for ICB to
develop partnerships with other Immunology and Molecular Cell Biology
journals published by NPG, a process that will help to enhance the editorial
content and international reputation of ICB."

Immunology and Cell Biology (ICB) has an illustrious 75 year history of
publishing high-quality international research. Its focus on the broad
fields of immunology and cell biology and its status as one of the leading
basic biological research journals in the Asia-Pacific region makes it an
ideal addition to NPG's portfolio of journals. This partnership is a part of
a major initiative of NPG Nature Asia-Pacific, a newly formed division of
NPG with offices in Tokyo, Hong Kong and Melbourne, in which it will partner
with scientific societies in this region to produce high-quality journals
(see link below for more information). ICB will be joining NPG's stable of
highly respected journals in Immunology and Molecular Cell Biology, which
include Nature Immunology, Nature Cell Biology, Nature Reviews Immunology,
The EMBO Journal and Genes and Immunity.

This new partnership will provide many benefits for authors of ICB papers
and readers of the journal. Papers published in the journal will receive
high exposure through nature.com, which currently has an average of 30
million page downloads per month, more press coverage and quick publication,
including publication ahead of print.

ICB will be able to take advantage of NPG's strengths: top-class editorial
expertise, pioneering technologies, innovative formats and world-class
production to provide premium information for scientific researchers in the
public and private sectors, government agencies and educators.

Another key strength of NPG is its close relationship with the scientific
community. By working in partnership with scientists, listening to what they
say, and always placing emphasis on quality rather than quantity, NPG is the
leading scientific publisher at finding innovative solutions to scientists'
information needs, both for the Nature-branded publications and those, like
ICB, published in partnership.

About ASI
The Australasian Society for Immunology Incorporated (ASI) was created by
the amalgamation in 1991 of the Australian Society for Immunology, formed in
1970, and the New Zealand Society for Immunology, formed in 1975. The aim of the Society is to encourage and support the discipline of immunology in the
Australasian region. It is a broadly-based Society, embracing clinical and
experimental, cellular and molecular immunology in humans and animals. The
Society provides a network for the exchange of information and for
collaboration within Australia, New Zealand and overseas. Further information is available at www.wehi.edu.au/collegiate/ASI/index.html

About NPG
Nature Publishing Group (NPG) is a division of Macmillan Publishers Ltd,
dedicated to serving the academic, professional scientific and medical
communities. NPG's flagship title, Nature, is the world's most highly-cited
weekly multidisciplinary journal and was first published in 1869. Other
publications and services include Nature research journals, Nature Reviews,
Nature Clinical Practice, a range of prestigious academic journals,
including society-owned publications, news content from [email protected] and scientific career information from Naturejobs.

NPG is a global company, with headquarters in London and offices in New
York, San Francisco, Washington DC, Boston, Tokyo, Paris, Munich, Hong Kong,
Melbourne, Gurgaon and Basingstoke. For more information, please go to
www.nature.com

Contact details:

David Swinbanks
Publishing Director,
NPG Nature Asia-Pacific
Tokyo, Japan
T: +81 3 3267 8764
E: [email protected]

Dr Philip Hodgkin
Walter and Eliza Hall Institute for Medical Research
Melbourne, Australia
T: +61 3 9345 2338
F: +61 3 9347 0852
E: [email protected]

Nick Campbell
Assistant Publisher
NPG Nature Asia-Pacific
Melbourne, Australia
T: +61 3 9825 1028
F: +61 3 9825 1010
E: [email protected]

Links:
NPG Nature Asia-Pacific: www.macmillan.com/09012006NPSAsiaPacificFinal.asp
Australasian Society for Immunology: www.wehi.edu.au/collegiate/ASI/index.html
Nature Publishing Group: www.nature.com

# # #

Published: 28 Feb 2006

Contact details:

The Macmillan Building, 4 Crinan Street
London
N1 9XW
United Kingdom

+44 20 7833 4000
Country: 
Journal:
News topics: 
Content type: 
Websites: 

http://www.wehi.edu.au/collegiate/ASI/index.html The Australasian Society for Immunology (ASI) http://www.nature.com Nature Publishing Group http://www.macmillan.com/09012006NPSAsiaPacificFinal.asp NPG Nature Asia-Pacific

Reference: 

Medicine